The firm sees the new panel as an important step forward in its strategy to further penetrate the molecular diagnostics market with its qPCR products.
Researchers from Protagen, Targos, and elsewhere have identified autoantibody biomarkers specific to patients diagnosed with prostate cancer.
Researchers in Belgium and the UK showed that their custom viral panel on Thermo Fisher's TaqMan qPCR array card is effective in samples from immunocompromised patients.
The product introduction comes about two years after the company merged with AmpliDiag and Genewave.
CEO Lars Kongsbak said that the proceeds will be used to strengthen the company's capital resources and to expand its inventory in light of growing demand for its qPCR arrays, miRcury microRNA microarrays, and other products and services.
Lonza is distributing Bar Harbor BioTechnology's new tools under an exclusive agreement.
NPR reports that researchers in Italy are testing a gene drive aimed at controlling mosquito populations.
Researchers may experience the effects of the government shutdown for a while, the Los Angeles Times reports.
A new study finds that the majority of patients at a Tijuana clinic received a diagnosis after first-line genome sequencing, the San Diego Union-Tribune reports.
In Genome Biology this week: post-transcriptional modification-based stratification of glioblastoma, single-cell analysis of gene expression and methylation in human iPSCs, and more.